Growth hormone therapy initiated before starvation ameliorates the catabolic state and enhances the protein-sparing effect of total parenteral nutrition
Authors:
- 1 June 1993
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 80 (6) , 740-744
Abstract
The effect of 7 days of subcutaneously administered bovine growth hormone (bGH) (0.2 mg kg−1 day−1; n = 4) or an equivalent volume of 0.15 mol l−1 saline (n = 3) on protein metabolism was assessed in lambs. The catabolic response to 48 h of starvation and subsequent hypocaloric total parenteral nutrition (TPN) was measured using primed constant intravenous infusions of [15N]urea and[14C]leucine. Following 48h, of starvation and 7 h of TPN, bGH-treated animals had a significantly decreased rate of net protein catabolism compared with controls (mean(s.e.m.) 2·4(0·2) versus 3·2(0·3)g kg−1 day−1, P < 0·01). The means(s.e.m.) rate of whole-body protein catabolism was also significantly decreased in bGH-treated animals at 10·9(0.3) g kg−1 day−1 compared with 12·9(0·7) g kg−1 day−1 in saline-treated controls (P < 0·05). In addition, the rates of net and whole-body protein catabolism decreased significantly (P < 0·05) during the period of hypocaloric parenteral feeding to mean(s.e.m.) values of 2·3(0·2) and 8·6(0·6) g kg−1 day−1 respectively in bGH-treated animals. By contrast, in saline-treated controls net and whole-body protein catabolism continued to increase during hypocaloric parenteral feeding. There was a significant decrease (P < 0·05) in the rate of[14C]leucine uptake in tissues of the gastrointestinal tract, heart and diaphragm in bGH-treated animals compared with controls. These results demonstrate that daily administration of growth hormone decreases the catabolic response to a metabolic stress, resulting in the conservation of protein in the heart, diaphragm, gastrointestinal tract and musculoskeletal system by a primary anticatabolic action. In addition, growth hormone therapy initiated before induction of the catabolic state enhances the protein-sparing effects of TPN. Further study is justified to determine whether growth hormone therapy initiated before elective or urgent surgery in the nutritionally depleted patient may have a role in reducing the severity of the postoperative catabolic state, particularly in the patient in whom a complicated course is anticipated.Keywords
Funding Information
- Health Research Council of New Zealand
This publication has 20 references indexed in Scilit:
- Perioperative Total Parenteral Nutrition in Surgical PatientsNew England Journal of Medicine, 1991
- Use of Human Growth Hormone Combined with Nutritional Support in a Critical Care UnitJournal of Parenteral and Enteral Nutrition, 1990
- Metabolic effects of recombinant human growth hormone: Isotopic studies in the postabsorptive state and during total parenteral nutritionBritish Journal of Surgery, 1990
- Insulinlike Growth Factor 1 Production Is Inhibited in Human SepsisArchives of Surgery, 1988
- Metabolie Effects of Recombinant Human Growth Hormone in Patients Receiving Parenteral NutritionAnnals of Surgery, 1988
- Influence of stress, depletion, and/or malignant disease on the responsiveness of surgical patients to total parenteral nutritionThe American Journal of Clinical Nutrition, 1988
- Weight Loss with Physiologic ImpairmentAnnals of Surgery, 1988
- The link between nutritional status and clinical outcome: can nutritional intervention modify it?The American Journal of Clinical Nutrition, 1988
- Whole Body Protein Kinetics in Severely Septic PatientsAnnals of Surgery, 1987
- MALNUTRITION IN SURGICAL PATIENTSThe Lancet, 1977